Biogen Balance Sheet
BIIB / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$29.4B
FY2025
Cash
N/A
Cash and equivalents
Total Debt
$6.3B
FY2025
Shareholder Equity
$18.3B
FY2025
Biogen had $29.4B in total assets and $18.3B in shareholders' equity as of FY2025. Total debt stood at $6.3B as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | - | - | - | - | - | $2.9B | $1.2B | $1.6B | $2.3B | $1.3B | $1.2B | $602.6M | $570.7M | $514.5M |
| Accounts Receivable | $1.3B | $1.4B | $1.7B | $1.7B | $1.5B | $1.9B | $1.9B | $2.0B | $1.8B | $1.4B | $1.2B | $1.3B | $824.4M | $686.8M | $584.6M |
| Inventory | $2.2B | $2.5B | $2.5B | $1.3B | $1.4B | $1.1B | $804.2M | $929.9M | $902.7M | $1.0B | $893.4M | $804.0M | $659.0M | $447.4M | $326.8M |
| Current Assets | $9.0B | $7.5B | $6.9B | $9.8B | $7.9B | $6.9B | $8.4B | $7.6B | $7.9B | $8.7B | $6.7B | $4.5B | $3.2B | $3.2B | $3.0B |
| PP&E (Net) | $3.1B | $3.2B | $3.3B | $3.3B | $3.4B | $3.4B | $3.2B | $3.6B | $3.2B | $2.5B | $2.2B | $1.8B | $1.8B | $1.7B | $1.6B |
| Goodwill | $6.5B | $6.5B | $6.2B | $5.7B | $5.8B | $5.8B | $5.8B | $5.7B | $4.6B | $3.7B | $2.7B | $1.8B | $1.2B | $1.2B | $1.1B |
| Total Assets | $29.4B | $28.0B | $26.8B | $24.6B | $23.9B | $24.6B | $27.2B | $25.3B | $23.7B | $22.9B | $19.5B | $14.3B | $11.9B | $10.1B | $9.0B |
| Current Liabilities | $3.3B | $5.5B | $3.4B | $3.3B | $4.3B | $3.7B | $4.9B | $3.3B | $3.4B | $3.4B | $2.6B | $2.2B | $1.8B | $1.7B | $912.9M |
| Total Debt | $6.3B | $6.3B | $6.9B | $6.3B | $6.3B | $7.4B | $4.5B | $5.9B | $5.9B | $6.5B | $6.5B | $580.3M | $592.4M | $687.4M | $1.0B |
| Shareholders' Equity | $18.3B | $16.7B | $14.8B | $13.4B | $10.9B | $10.7B | $13.3B | $13.0B | $12.6B | $12.1B | $9.4B | $10.8B | $8.6B | $7.0B | $6.4B |